Navigation Links
Systems biology recommended as a clinical approach to cancer
Date:7/9/2009

Blacksburg, Va. -- Four researchers at the Virginia Bioinformatics Institute (VBI) at Virginia Tech and their colleagues at the Wake Forest University School of Medicine are advocating the use of systems biology as an innovative clinical approach to cancer. This approach could result in the development of improved diagnostic tools and treatment options, as well as potential new drug targets to help combat the many potentially fatal types of the disease.

In an upcoming paper* in Biochimica et Biophysica Acta, the international journal of biochemistry, biophysics and molecular biology, the team highlights the usefulness of a systems biology approach in developing a comprehensive view of cancer diseases, which will help researchers better understand the complex processes related to cancer progression, diagnosis, and treatment. Systems biology brings together mathematical modeling, simulations, and quantitative experiments, allowing researchers to use the data of one of the approaches to repeatedly define the framework of the other approaches. Biochemical networks are central to biological function, while computer models provide a particularly useful way to understand their workings. Biochemical models are the ideal means to design and predict the effect of interventions, such as cancer treatments.

"One of the goals of this paper is to show the potential benefits that can result from moving the use of systems biology techniques closer to the clinic," explained VBI Professor Reinhard Laubenbacher. "We believe this kind of shift is very possible. For example, mathematical models could integrate patient characteristics to help researchers determine the features of dynamic processes linked to cancer progression, diagnosis, and treatment. Systems biology has an increasingly important role in cancer research and treatment, especially as mathematical modelers, biologists, and clinicians continue working together. Through these transdisciplinary efforts, the needs of the clinic can directly impact work in the laboratory."

According to the researchers, before the functional differences between a cancer cell and a normal cell can be understood, an assessment of the overall biochemical network, not just the individual molecular mechanisms involved, is needed. A more complete picture of the system's dynamic characteristics can help contribute to the development of improved diagnostics and techniques that can disrupt the progression of the disease. They discuss three case studies related to diagnostics, therapy, and drug development in detail to demonstrate how a systems-level view can provide important insights related to the disease. The examples, which involve cases of breast cancer, B-cell lymphomas, and colorectal cancer, demonstrate the various kinds of clinical issues that can arise, as well as the use of different mathematical methods that can be used in a systems biology approach.

According to Wake Forest University Professor of Medicine Steve Akman, "The systems biology approach provides an opportunity for major advancements in our understanding of carcinogenesis. Cancer biologists are just beginning to understand what mathematicians, engineers, and computer scientists have long known that the behavior of dynamic systems are more than just the sum of the individual components. The VBI-Wake Forest collaborative group was established in response to the realization that the potential applications of systems biology to the cancer problem will be effected only through collaborations between cancer biologists, mathematicians, engineers, and computer scientists."


'/>"/>

Contact: Susan Bland
subland@vbi.vt.edu
540-231-7912
Virginia Tech
Source:Eurekalert

Related biology news :

1. Systems Biology poised to revolutionize the understanding of cell function and disease
2. Cogent Systems and Northrop Grumman Reach Agreement to Settle Automated Fingerprint Identification Technology Suit and Create Strategic Alliance
3. Radiant Systems Selects BIO-key(R) Biometric Software for POS Solution
4. Fujitsu and HT Systems Partner to Provide Biometric Patient Identity Management
5. Fujitsu and HT Systems Partner to Provide Biometric Patient Identity Management
6. Radiant Systems Selects BIO-key(R) Biometric Software for POS Solution
7. Cogent Systems and Northrop Grumman Reach Agreement to Settle Automated Fingerprint Identification Technology Suit and Create Strategic Alliance
8. Smartcard Finger-Match Add-on for VeriFinger and MegaMatcher is Now Available for the Implementation of Biometric Fingerprint-on-Smartcard Verification Systems
9. Study shows genetically engineered corn could affect aquatic ecosystems
10. Genetically engineered corn may harm stream ecosystems
11. NYUs Center for Genomics & Systems Biology receives $4.4 million NSF grant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/1/2016)... 1, 2016 Rising sales of ... global touchfree intuitive gesture control market size ... sales of consumer electronics coupled with new technological advancements ... size through 2020   --> ... new technological advancements to drive global touchfree intuitive gesture ...
(Date:1/28/2016)... 2016 Synaptics (NASDAQ: SYNA ), a leading developer ... quarter ended December 31, 2015. --> ... 2016 increased 2 percent compared to the comparable quarter last year ... 2016 was $35.0 million, or $0.93 per diluted share. ... the first quarter of fiscal 2016 grew 9 percent over the ...
(Date:1/25/2016)... SEATTLE , Jan. 25, 2016  Glencoe Software, ... biotech, pharma and publication industries, will provide the data ... Phenotypic Screening Centre (NPSC). ... Phenotypic analysis ... even whole organisms, allowing comparisons between states such as ...
Breaking Biology News(10 mins):
(Date:2/10/2016)... 2016 NX Prenatal Inc., a US ... technology for early warning of adverse pregnancy outcomes, ... study by Dr. Thomas McElrath of ... Fetal Medicine,s (SMFM) annual meeting held in ... 2016.  The presentation reported initial positive top-line results ...
(Date:2/10/2016)... -- IsoRay, Inc. (NYSE MKT: ISR), a medical technology company ... for the treatment of prostate, brain, lung, head and ... for the second quarter and six months of fiscal ... --> --> Revenue was $1.19 ... ended December 31, 2015, a 12% increase compared to ...
(Date:2/10/2016)... ... February 10, 2016 , ... Benchmark Research, ... the promotion of two long-standing principal investigators (PI) to the roles of Chief ... and Development. , Dr. Laurence Chu, a Benchmark Research PI in the Austin ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... expansion to their comprehensive training and support program, Sonalinkā„¢ remote monitoring. The inaugural ... procedures performed on Friday, February 5th, connecting Dr. Samuel Peretsman to a HIFU ...
Breaking Biology Technology: